NCT02918253View on ClinicalTrials.gov

HDR Focal: Feasibility Study

NARecruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

October 14, 2016

Primary Completion Date

November 30, 2027

Study Completion Date

December 31, 2027

Conditions

Prostate Cancer

Interventions

RADIATION

targeted focal HDR brachytherapy

RADIATION

Whole-gland HDR Brachytherapy

Control/Standard of Care

Trial Locations (1)

M5G 2M9

RECRUITING

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors

lead

University Health Network, Toronto

OTHER